How can the gene therapy industry drive down the cost of goods to better serve patients?

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.

The cost per dose of viral vector therapeutics is a major challenge for the widespread accessibility of gene therapy products, driven by a high cost of goods and manufacturing expenses.

In this webinar, we will identify the components that contribute to these high costs and pinpoint the biggest challenges the industry must overcome to reduce the cost per dose. We will discuss how tools such as process intensification (PI) and cost modeling can help us understand the main cost drivers and the impact process optimization can have on the cost per dose.

• Discover why viral vector therapies are so expensive
• Explore how manufacturers and solution providers can work together to ultimately make these drugs more cost-efficient to manufacture and ultimately reduce cost per dose
• Dive into case study examples showing how the use of PI can help reduce the cost of manufacturing and ultimately cost per dose

Emmanuelle Cameau

Strategic Technology Partnership Leader Cytiva, Genomic Medicines

Emmanuelle Cameau is a Senior Bioreactor Applications Scientist within the Scientific Laboratory Services (SLS) at Pall Biotech. Highly skilled in the field of cell culture applications and with 10+ years of experience, Emmanuelle previously held positions as a Bioprocess Specialist at Pall, and a Biotech Process Sciences Upstream Process Development Engineer at Merck Serono. She received her Biotechnology Engineer diploma from the former Ecole Supérieure d’Ingénieurs de Luminy (now Polytech Marseille).

Watch now

SPEAKERS

Emmanuelle Cameau

Strategic Technology Partnership Leader Cytiva, Genomic Medicines

You might also like

How to apply quality by design principles to cell and gene therapy release testing

Audrey Chang

30 November 2023

Watch

Case study: becoming the first GMP-certified cell and gene therapy manufacturing facility in Thailand

Kitipong Uaesoontrachoon

28 November 2023

Watch

From concept to clinic: overcoming the challenges of potency assays in cell and gene therapy development

Audrey Chang, Joe Newcome

10 December

in 19

Days

Register

Revolutionizing cell and gene therapy with digitalization: a panel discussion with industry leaders

C Harrison, R Street-Howards, K Deshpande

8 October

Watch

Preparing for success in gene therapy purification

X Fu, A Tustian, A Sharma et al.

9 October

Watch